Cardiovascular clinical trials
Cardiovascular clinical trials are usually complex, often competitive, and almost always challenging. Finding, engaging, recruiting and retaining vulnerable cardiovascular patient populations, especially since the advent of COVID-19, is a formidable task.
Why AES for cardiovascular clinical trials?
AES brings the precise mix of expertise, insights, specialists and infrastructure necessary to overcome these challenges. We know that the details make the difference for a patient population that may find the demands of a clinical trial to be particularly burdensome. Identifying qualified patients near but unknown to research sites, for example, helps ease travel burdens. Having cardiologists on site who deeply understand the patient journey improves the patient experience. And having AES sites situated in the community—not at hospitals—brings more comfort and accessibility to a patient population at high risk for potential COVID-19 complications.
Other key AES differentiators include:
More than 55 sites globally with extensive cardiac experience, and several of which are located near a 125,000-person retirement community in Florida
A network of partner cardiologists, including subspecialists and interventionalists, who have diverse specialties and experience and who support trials by serving as investigators and/or by providing referrals
A proprietary database of over 40 million patients with cardiovascular disease, risk factors and comorbidities highly predictive of a randomized heart failure patient, including over 10 million patients who have provided race and ethnicity information. This important demographic and behavioral information helps us understand how to engage these patients.
Potential patients in database
Targeted outreach strategies in specific communities
We have proven methodologies to engage diverse populations often underrepresented in access to medical treatment and clinical research. For these groups, participating in a clinical trial is a burden that can be particularly acute. That’s why our messaging and creative is specifically tailored to take into account the perceptions and needs of diverse populations, including their attitudes toward clinical research and their motivations and barriers to become involved.
In addition to traditional outreach via social media, direct mail, etc., we access volunteers through familiar, local and well-trusted connections within their community (e.g., outreach to community- and faith-based organizations), as well as through our global network of providers and healthcare systems. We then offer flexible scheduling, virtual first office visits and minority investigators/staff at the site to improve the volunteer experience.